CTIS2023-507137-24-00
Recruiting
Phase 1
A pilot single center, open label trial to assess the impact of doxycycline postexposure prophylaxis on antimicrobial resistance - ITM202302
Institute Of Tropical Medicine0 sites78 target enrollmentOctober 5, 2023
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Bacterial sexually transmittable diseases (chlamydia, gonorrhea, syphilis)
- Sponsor
- Institute Of Tropical Medicine
- Enrollment
- 78
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Able and willing to provide written informed consent, Age 18 years old or older, Eligible to take HIV PrEP, Male sex at birth
Exclusion Criteria
- •Use of any antibiotics in the previous 3 months, Known contra\-indications or allergy to doxycycline, gluten or lactose, Currently using or planning to use anticoagulants based on vitamin K antagonism (warfarin, acenocoumarol, fenprocoumon)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A single center, open-labeled, pilot study to evaluate the safety and efficacy of cardiac cycle-synchronized electrical lower limb muscle stimulation therapy for cardiovascular diseaseatent heart failure (NYHA class: II-III), ischemic heart disease (CCS class: II-III), peripheral artery disease (Fontaine class: II-IV), pulmonary artery hypertension (WHO class: II-III), and healthy adultJPRN-UMIN000026841Kurume University School of Medicine, Division of Cardiovascular Medicine, Department of Internal Medicine30
Not yet recruiting
Phase 1
Biocompatible & Biodegradable Polymeric Skin Grafts for WoundsHealth Condition 1: T758- Other specified effects of external causesCTRI/2020/11/029284SASTRA Deemed University
Active, not recruiting
Phase 1
A pilot study to assess the efficacy and safety of CBD oral solution in addition to standard treatment for pediatric subjects with Developmental and Epileptic EncephalopathyDevelopmental and Epileptic Encephalopathy (DEE)MedDRA version: 20.0Level: PTClassification code 10077380Term: Epileptic encephalopathySystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2019-001633-14-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA20
Withdrawn
Phase 1
A SINGLE CENTER OPEN-LABEL PILOT STUDY TO EVALUATE THE TOLERABILITY AND SAFETY OF A SYNTHETIC SOFT TISSUE IMPLANT MATERIAL IN THE SKIN OF NORMAL VOLUNTEERSTolerability and safety of a new synthetic soft tissue implant material for soft tissue augmentation in healthy volunteers.Surgery - Other surgeryACTRN12607000223437COSMETREND PTY LTD8
Completed
Not Applicable
A single centre, open label trial investigating the absorption, metabolism and excretion of somapacitan after single subcutaneous dosing in healthy male subjectsgroeihormoondeficientiegrowth hormone deficiencyNL-OMON42854ovo Nordisk A/S7